Cargando…
Protective Effects of Glucose-Related Protein 78 and 94 on Cisplatin-Mediated Ototoxicity
Cisplatin is a widely used chemotherapeutic drug for treating various solid tumors. Ototoxicity is a major dose-limiting side effect of cisplatin, which causes progressive and irreversible sensorineural hearing loss. Here, we examined the protective effects of glucose-related protein (GRP) 78 and 94...
Autores principales: | Yi, Junyeong, Kim, Tae Su, Pak, Jhang Ho, Chung, Jong Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465420/ https://www.ncbi.nlm.nih.gov/pubmed/32748834 http://dx.doi.org/10.3390/antiox9080686 |
Ejemplares similares
-
Antioxidant Therapy against Oxidative Damage of the Inner Ear: Protection and Preconditioning
por: Pak, Jhang Ho, et al.
Publicado: (2020) -
Protective effect of berberine chloride against cisplatin-induced ototoxicity
por: Kim, Jong-Heun, et al.
Publicado: (2021) -
Cisplatin ototoxicity histopathology
por: Hodge, Sarah E., et al.
Publicado: (2021) -
Calpain mediated cisplatin-induced ototoxicity in mice
por: Chang, Liang, et al.
Publicado: (2013) -
Protective Effect of Minocycline Against Cisplatin-induced Ototoxicity
por: Lee, Chi-Kyou, et al.
Publicado: (2011)